Seeking Alpha

Helix BioPharma (HBP -3.6%) falls after saying the clinical hold on its new drug application for...

Helix BioPharma (HBP -3.6%) falls after saying the clinical hold on its new drug application for its cervical lesion drug trial has been removed by the FDA, however the company still lacks the funding to start the trial.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|